SCHEMBL879300

SCHEMBL879300

Cc1ccc(-c2ccc3[nH]c4c(ccc5c(C=O)c[nH]c54)c3c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 10/20 0.71
PIM1 P11309 8/20 0.66
PIM2 Q9P1W9 2/20 0.60
TRIM24 O15164 1/20 0.44
TRIM33 Q9UPN9 1/20 0.44
ICMT O60725 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.39
CYP2A6 P11509 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844836 0.88 PIM3 (0.70) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL845204 0.88 PIM3 (0.70) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844520 0.87 PIM3 (0.78) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844605 0.84 PIM3 (0.64) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844626 0.83 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844630 0.82 PIM3 (0.57) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL15330072 0.82 ALDH1A1 (0.56) PIM3PIM1TRIM24TRIM33ICMT
SCHEMBL845188 0.81 PIM3 (0.60) PIM3PIM1PIM2ALDH1A1KDM4E
SCHEMBL10079034 0.80 PIM3 (0.71) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844850 0.80 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors PIM3, PIM1, PIM2 PIM3 1/4885PIM1 2/4885PIM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.